(Total Views: 733)
Posted On: 09/20/2020 10:26:34 PM
Post# of 145909
Investors who don’t agree with your overzealous, or “NP view,” of a buyout # aren’t pharma moles. They are likely investors who see an excellent return at $25.
Could the stock go to $50? Maybe. Could it also go back to .30? Yes. We ar where to discuss both possibilities and make the best decision.
Could the stock go to $50? Maybe. Could it also go back to .30? Yes. We ar where to discuss both possibilities and make the best decision.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)